Published in Cost Eff Resour Alloc on May 31, 2006
Medical costs of abnormal serum sodium levels. J Am Soc Nephrol (2008) 1.56
Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion. Eur J Endocrinol (2011) 1.54
Prevalence, incidence and etiology of hyponatremia in elderly patients with fragility fractures. PLoS One (2014) 1.23
Prevalence of hyponatremia and association with mortality: results from NHANES. Am J Med (2013) 1.22
Principles of management of severe hyponatremia. J Am Heart Assoc (2013) 1.12
Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats. Age (Dordr) (2012) 1.05
Prevalence of hyponatremia in femur neck fractures: a one-year survey in an urban emergency department. Adv Orthop (2014) 0.94
SIADH and hyponatraemia: foreword. NDT Plus (2009) 0.85
Retrospective evaluation of standard diagnostic procedures in identification of the causes of new-onset syndrome of inappropriate antidiuresis. Int J Med Sci (2014) 0.82
SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan. Support Care Cancer (2015) 0.81
Hyponatremia may reflect severe inflammation in children with febrile urinary tract infection. Pediatr Nephrol (2012) 0.81
Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study. Ann Gen Psychiatry (2008) 0.80
Body sodium, potassium and water in peritoneal dialysis-associated hyponatremia. Perit Dial Int (2014) 0.79
ΔFosB in the supraoptic nucleus contributes to hyponatremia in rats with cirrhosis. Am J Physiol Regul Integr Comp Physiol (2012) 0.78
A cross-sectional study of hyponatraemia among elderly patients with heart failure in Uganda. BMJ Open (2016) 0.77
Incidence, Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery: Experience with 344 Consecutive Patients at a Single Tertiary Center. J Clin Med (2014) 0.76
Lixivaptan - an evidence-based review of its clinical potential in the treatment of hyponatremia. Core Evid (2013) 0.75
ANG II receptor subtype 1a gene knockdown in the subfornical organ prevents increased drinking behavior in bile duct-ligated rats. Am J Physiol Regul Integr Comp Physiol (2014) 0.75
Consensus development methods, and their use in clinical guideline development. Health Technol Assess (1998) 11.56
Consensus methods: characteristics and guidelines for use. Am J Public Health (1984) 11.53
Hyponatremia. N Engl J Med (2000) 11.31
A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med (1957) 6.11
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation (1990) 3.72
Annual direct cost of urinary incontinence. Obstet Gynecol (2001) 3.35
Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med (1997) 3.26
Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med (1985) 2.82
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation (1986) 2.69
Hyponatraemia: mechanisms and management. Lancet (1981) 2.55
The clinician's illusion. Arch Gen Psychiatry (1984) 2.55
Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta (2003) 2.03
Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest (1993) 1.83
Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics (2004) 1.58
Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. Am J Manag Care (1999) 1.47
Medical care services in the Consumer Price Index. Mon Labor Rev (1978) 1.45
Cost-of-illness studies: a major headache? Pharmacoeconomics (1992) 1.44
Validity of hospital discharge International Classification of Diseases (ICD) codes for identifying patients with hyponatremia. J Clin Epidemiol (2003) 1.33
Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1) N Engl J Med (1988) 1.30
Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med (1996) 1.30
Admission hyponatremia in the elderly: factors influencing prognosis. J Gen Intern Med (1994) 1.26
[Incidence, causes and prognostic factors of hyponatremia in intensive care]. Rev Med Interne (2003) 1.23
Hyponatremia in a nursing home population. J Am Geriatr Soc (1995) 1.21
The cost of illness of pressure ulcers in The Netherlands. Adv Skin Wound Care (2002) 1.18
Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am (2003) 1.14
Incidence and etiology of hyponatremia in an intensive care unit. Clin Nephrol (1990) 1.12
Consequences of hyponatraemia and hypernatraemia in children with acute diarrhoea in Bangladesh. Br Med J (Clin Res Ed) (1983) 1.09
Hyponatremia in a hospital population. J Med (1991) 1.08
The prognosis of hyponatremia at hospital admission. J Gen Intern Med (1987) 1.05
Hyponatremia as observed in a chronic disease facility. J Am Geriatr Soc (1979) 1.03
Predictors of outcome in hospitalized patients with severe hyponatremia. J Natl Med Assoc (2003) 0.95
Reproducibility of a consensus panel in the interpretation of coronary angiograms. Am Heart J (1978) 0.95
The syndrome of inappropriate antidiuretic hormone secretion in the elderly. Am J Med (1997) 0.87
Cost of refractory epilepsy in adults in the USA. Epilepsy Res (1996) 0.83
Annual cost of erectile dysfunction to UK Society. Pharmacoeconomics (1999) 0.81
Prognostic value of hyponatremia in patients with severe chronic heart failure. Angiology (1990) 0.79
Scoring patient management problems: external validation of expert consensus. Eval Health Prof (1982) 0.78
Follow up of 742 tuberculosis patients. Follow up at eighteen months of 742 tuberculosis patients notified in midlands and south-eastern province in six months in 1964. Cent Afr J Med (1967) 0.78
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med (2006) 10.63
Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol (2010) 3.64
Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health (2006) 2.44
Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality. Am J Physiol Renal Physiol (2005) 2.04
Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007. Clin J Sport Med (2008) 1.54
Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study. Eur J Heart Fail (2011) 1.50
Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol (2007) 1.48
Hindbrain chemical mediators of reflex-induced inhibition of gastric tone produced by esophageal distension and intravenous nicotine. Am J Physiol Regul Integr Comp Physiol (2005) 1.47
A review of the economic burden of ADHD. Cost Eff Resour Alloc (2005) 1.39
Hyponatremia in marathon runners due to inappropriate arginine vasopressin secretion. Am J Med (2007) 1.29
Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats. J Pharmacol Exp Ther (2003) 1.28
Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss. J Biol Chem (2010) 1.24
Diabetes insipidus as a complication after pituitary surgery. Nat Clin Pract Endocrinol Metab (2007) 1.21
Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am (2003) 1.14
Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002. Inflamm Bowel Dis (2008) 1.13
Updated fluid recommendation: position statement from the International Marathon Medical Directors Association (IMMDA). Clin J Sport Med (2006) 1.08
Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats. Age (Dordr) (2012) 1.05
Sex differences in vasopressin V₂ receptor expression and vasopressin-induced antidiuresis. Am J Physiol Renal Physiol (2010) 1.02
Osmotic and nonosmotic regulation of arginine vasopressin during prolonged endurance exercise. J Clin Endocrinol Metab (2008) 0.99
A reevaluation of the effects of stimulation of the dorsal motor nucleus of the vagus on gastric motility in the rat. Am J Physiol Regul Integr Comp Physiol (2006) 0.99
Regulation of gene expression in magnocellular neurons in rat supraoptic nucleus during sustained hypoosmolality. Endocrinology (2004) 0.98
Use of steroid profiles in determining the cause of adrenal insufficiency. Steroids (2006) 0.97
Increased blood pressure, aldosterone activity, and regional differences in renal ENaC protein during vasopressin escape. Am J Physiol Renal Physiol (2004) 0.96
Synergistic effects of nitric oxide and prostaglandins on renal escape from vasopressin-induced antidiuresis. Am J Physiol Regul Integr Comp Physiol (2002) 0.95
Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings. J Manag Care Pharm (2005) 0.95
Dysregulation of renal salt and water transport proteins in diabetic Zucker rats. Kidney Int (2002) 0.94
Disorders of water and salt metabolism associated with pituitary disease. Endocrinol Metab Clin North Am (2008) 0.94
Acute changes in endocrine and fluid balance markers during high-intensity, steady-state, and prolonged endurance running: unexpected increases in oxytocin and brain natriuretic peptide during exercise. Eur J Endocrinol (2008) 0.92
Glucose does not activate nonadrenergic, noncholinergic inhibitory neurons in the rat stomach. Am J Physiol Regul Integr Comp Physiol (2004) 0.92
Selective gene expression in magnocellular neurons in rat supraoptic nucleus. J Neurosci (2004) 0.92
Estrogen regulates adrenal angiotensin AT1 receptors by modulating AT1 receptor translation. Endocrinology (2003) 0.92
Age-associated abnormalities of water homeostasis. Endocrinol Metab Clin North Am (2013) 0.91
Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015. Clin J Sport Med (2015) 0.90
Glucose acts in the CNS to regulate gastric motility during hypoglycemia. Am J Physiol Regul Integr Comp Physiol (2003) 0.89
Sex and the basic scientist: is it time to embrace Title IX? Biol Sex Differ (2013) 0.89
Increased renal alpha-ENaC and NCC abundance and elevated blood pressure are independent of hyperaldosteronism in vasopressin escape. Am J Physiol Renal Physiol (2006) 0.89
Increased renal ENaC subunit and sodium transporter abundances in streptozotocin-induced type 1 diabetes. Am J Physiol Renal Physiol (2003) 0.89
Characterization of noradrenergic transmission at the dorsal motor nucleus of the vagus involved in reflex control of fundus tone. Am J Physiol Regul Integr Comp Physiol (2008) 0.88
Sodium homeostasis and bone. Curr Opin Nephrol Hypertens (2014) 0.87
Melanocortin signaling in the brainstem influences vagal outflow to the stomach. J Neurosci (2013) 0.86
Downregulation of renal vasopressin V2 receptor and aquaporin-2 expression parallels age-associated defects in urine concentration. Am J Physiol Renal Physiol (2004) 0.86
Conivaptan: Evidence supporting its therapeutic use in hyponatremia. Core Evid (2010) 0.84
Dorsal motor nucleus of the vagus: a site for evoking simultaneous changes in crural diaphragm activity, lower esophageal sphincter pressure, and fundus tone. Am J Physiol Regul Integr Comp Physiol (2007) 0.83
Disorders of body water homeostasis in critical illness. Endocrinol Metab Clin North Am (2006) 0.82
Systemic sclerosis prevalence and comorbidities in the US, 2001-2002. Curr Med Res Opin (2008) 0.82
Small interfering RNA-mediated functional silencing of vasopressin V2 receptors in the mouse kidney. Physiol Genomics (2005) 0.81
Models of interinstitutional partnerships between research intensive universities and minority serving institutions (MSI) across the Clinical Translational Science Award (CTSA) consortium. Clin Transl Sci (2013) 0.80
Systemic diseases associated with disorders of water homeostasis. Endocrinol Metab Clin North Am (2002) 0.80
Abnormalities of water homeostasis in aging. Endocrinol Metab Clin North Am (2005) 0.80
Changes in copeptin and bioactive vasopressin in runners with and without hyponatremia. Clin J Sport Med (2011) 0.78
Regulation of renal salt and water transporters during vasopressin escape. Prog Brain Res (2002) 0.78
Dysnatremia predicts a delayed recovery in collapsed ultramarathon runners. Clin J Sport Med (2007) 0.77
Inhibition of salt appetite in rats by central oxytocin. Am J Physiol Regul Integr Comp Physiol (2004) 0.77
The need for salt: does a relationship exist between cystic fibrosis and exercise-associated hyponatremia? J Strength Cond Res (2014) 0.77
Sodium status of collapsed marathon runners. Arch Pathol Lab Med (2005) 0.76
Role of thromboxane receptors in the dipsogenic response to central angiotensin II. Am J Physiol Regul Integr Comp Physiol (2002) 0.76
Changes in steroid concentrations with the timing of corticotropin stimulation testing in participants with adrenal sufficiency. Endocr Pract (2012) 0.75
Development of an experimental model to study the pathophysiology of cerebral salt wasting following subarachnoid hemorrhage. Acta Neurochir Suppl (2012) 0.75
Comments on: "Esophageal-gastric relaxation reflex in rat: dual control of peripheral nitrergic and cholinergic transmission". Am J Physiol Regul Integr Comp Physiol (2006) 0.75
Correction: Hyponatremia Improvement Is Associated with a Reduced Risk of Mortality: Evidence from a Meta-Analysis. PLoS One (2016) 0.75
Incorporating pharmacoeconomic and health outcomes into randomized clinical trials. Expert Rev Pharmacoecon Outcomes Res (2005) 0.75